Form 8-K - Current report:
SEC Accession No. 0001493152-22-001725
Filing Date
2022-01-20
Accepted
2022-01-20 16:15:49
Documents
14
Period of Report
2022-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44077
2 ex10-1.htm EX-10.1 61092
3 ex10-2.htm EX-10.2 68412
  Complete submission text file 0001493152-22-001725.txt   381232

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lucd-20220117.xsd EX-101.SCH 3054
5 XBRL LABEL FILE lucd-20220117_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE lucd-20220117_pre.xml EX-101.PRE 22609
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3734
Mailing Address ONE GRAND CENTRAL PLACE, SUITE 4600 NEW YORK NY 10165
Business Address ONE GRAND CENTRAL PLACE, SUITE 4600 NEW YORK NY 10165 212 949 4319
Lucid Diagnostics Inc. (Filer) CIK: 0001799011 (see all company filings)

EIN.: 825488042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40901 | Film No.: 22542470
SIC: 3841 Surgical & Medical Instruments & Apparatus